Health Condition 1: null- Fibromyalgia patients with chronic pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult females (age 18-50 years) diagnosed with Fibromyalgia
Exclusion criteria
Exclusion criteria: a) Pregnant and lactating mothers. b) Concomitant diseases such as osteomalacia, metabolic bone diseases, hyperthyroidism, and other chronic diseases. c) When medicines such as analgesics, anti-inflammatory or psychotropic cannot be stopped for even two days. d) A history of seizures, brain trauma, brain surgery or intracranial hypertension, pace maker or other metallic implants e) Contra-indications for TMS f) Inflammation in the joints h) abnormal levels of luteinizing hormone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The decrease in LH level in response to sucrose challenge test is deranged in fibromyalgia patients The nociceptive flexion reflex/R-III and other objective methods of pain are affected by rTMSTimepoint: Outcome name:Oral sucrose challenge test, 25gm/100 ml, pre and post rTMS, Time points:5 weeks Outcome name: Determination of Pain threshold and latency, pre and post rTMS,Time points: 5 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain in fibromyalgia is mediated by opioids rTMS is effective therapy for treatment of fibromyalgiaTimepoint: Outcome name:Oral sucrose challenge test, 25gm/100 ml, pre and post rTMS, Time points:6 months, 1 year Outcome name: rTMS, 30 min/day/20 sessions, Time points:4 weeks | — |
Countries
India
Contacts
All India Institute of Medical Sciences, New Delhi